STOCK TITAN

Pediatrix (MD) EVP Mary Ann Moore reports 36,814-share bona fide stock gifts

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Pediatrix Medical Group EVP and General Counsel Mary Ann E. Moore reported bona fide gifts of 36,814 shares of common stock. The transactions on June 9, 2026 moved 18,407 shares to a family trust and 18,407 shares from her direct holdings. After these transfers, she holds 78,059 shares directly and 111,831 shares indirectly through the trust, with beneficial interest limited to her pecuniary stake.

Positive

  • None.

Negative

  • None.
Insider Moore Mary Ann E
Role EVP, GC, Chief Admin Off & Sec
Type Security Shares Price Value
Gift Common Stock 18,407 $0.00 --
Gift Common Stock 18,407 $0.00 --
Holdings After Transaction: Common Stock — 78,059 shares (Direct, null); Common Stock — 111,831 shares (Indirect, By Trust)
Footnotes (1)
  1. On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust. The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
Total gifted shares 36,814 shares Bona fide gifts of common stock on June 9, 2026
Gift per transaction 18,407 shares Each of two gift transactions of common stock
Direct holdings after 78,059 shares Common stock held directly following transactions
Indirect holdings after 111,831 shares Common stock held indirectly through trust following transactions
Price per gifted share $0.00 Reported transaction price per share for gift code G
bona fide gift financial
"The transaction code description is "Bona fide gift" for both entries."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
pecuniary interest financial
"The reporting person disclaims beneficial interest except to the extent of her pecuniary interest."
indirect ownership financial
"The trust-held securities are reported as indirect ownership marked "By Trust"."
trustees financial
"The reporting person and her spouse are trustees of the trust that holds the reported securities."
Trustees are people or a small group legally appointed to hold and manage assets, documents, or obligations on behalf of others and must act in those beneficiaries’ best interests. Think of them as a neutral guardian or custodian who enforces rules, protects assets, and makes decisions that can affect payments, corporate governance, or recovery in a default — all of which directly influence investor returns and risk.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moore Mary Ann E

(Last)(First)(Middle)
1301 CONCORD TERRACE

(Street)
SUNRISE FLORIDA 33323

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, GC, Chief Admin Off & Sec
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/09/2026G18,407(1)D$0.0078,059D
Common Stock06/09/2026GV18,407(1)A$0.00111,831IBy Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. On June 9, 2026, the reporting person transferred 18,407 shares of common stock to a trust of which the reporting person and her spouse are trustees. Members of the reporting person's immediate family are the beneficiaries of the trust.
2. The reporting person and her spouse are trustees of the trust that holds the reported securities. The reporting person disclaims beneficial interest of the reported securities except to the extent of her pecuniary interest therein.
/s/ Mary Ann E. Moore06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Pediatrix (MD) executive Mary Ann E. Moore report in this Form 4?

Mary Ann E. Moore reported bona fide gifts of Pediatrix common stock totaling 36,814 shares. The gifts involved transfers between her direct holdings and a family trust, with no sale proceeds or option exercises disclosed in this filing.

How many Pediatrix (MD) shares did Mary Ann E. Moore gift?

She reported gifting 36,814 shares of Pediatrix common stock in total. This consisted of two bona fide gift transactions of 18,407 shares each, one relating to a family trust and one from her direct ownership position, both at zero consideration.

What are Mary Ann E. Moore’s Pediatrix (MD) holdings after these transactions?

After the reported gifts, Mary Ann E. Moore holds 78,059 Pediatrix shares directly and 111,831 shares indirectly. The indirect holdings are in a trust where she and her spouse are trustees, with immediate family members as beneficiaries, as disclosed in the footnotes.

How is the family trust involved in Mary Ann E. Moore’s Pediatrix (MD) Form 4?

One transaction moved 18,407 shares to a trust where Moore and her spouse are trustees. The trust’s beneficiaries are her immediate family members, and she disclaims beneficial interest in those securities except for her pecuniary interest, according to the footnotes.

Were Mary Ann E. Moore’s Pediatrix (MD) transactions open-market sales or purchases?

No, the Form 4 classifies both transactions as bona fide gifts of common stock. The transaction code is G, with a reported price of zero per share, indicating non-market transfers rather than open-market buying or selling activity.

Does Mary Ann E. Moore retain beneficial ownership of the Pediatrix (MD) trust shares?

She and her spouse serve as trustees of the trust holding the reported shares. She disclaims beneficial interest in those securities except to the extent of her pecuniary interest, meaning economic benefits are limited to her financial stake as described.